CRISPR Technology Market – Top 3 Players and there Market Growth

04.12.2019 - 12:57 | 1776643

Artikel von marketsandmarkets

The CRISPR technology market include the rising funding from government and private organizations and the high adoption of CRISPR technology.

The CRISPR technology market include the rising funding from government and private organizations and the high adoption of CRISPR technology.

Market Size
The global CRISPR Technology market size is projected to reach USD 562 million in 2018 to USD 1,715 million by 2023, at a CAGR of 25%.

Cellecta, Inc. (US), Thermo Fisher (US), GeneCopoeia, Inc. (US), Applied StemCell (US), Synthego Corporation (US), OriGene Technologies (US), Horizon Discovery (UK), Merck (Germany), and GenScript (US) are some key players in this market. These companies are focusing on increasing their presence in the high-growth markets through both organic as well as inorganic growth strategies such as product launches, acquisitions, and expansions.

For More Details, Download a PDF Brochure:-

“Thermo Fisher Scientific has established its presence in diversified life sciences markets; this has helped it to minimize risks and dependency on any particular business segment”
The company has a strong product portfolio and brand image, which enables it to strengthen its position in the market. It has strong R&D capabilities, which provide it a strategic advantage over its competitors. The company focuses on obtaining market-driven solutions to meet the increasing demand for CRISPR-edited genes. It is involved in various growth initiatives such as product launches and agreements. For instance, in 2015, Thermo Fisher Scientific signed a license agreement, to be renewed yearly, with ToolGen (South Korea) for ToolGen’s intellectual property portfolio of CRISPR-Cas9 technology.

“Merck is also an established player in the life sciences industry”
The company leads in terms of operational and financial strength and has focused on growth in the CRISPR technology market through organic growth strategies. Merck was also the first company to manufacture arrayed CRISPR libraries that covered the entire human genome. This was done in collaboration with the Wellcome Trust Sanger Institute. These arrayed CRISPR libraries helped researchers in drug discovery, disease research, and gene therapy. Arrayed CRISPR libraries have been an important technological advancement in genome editing and helped Merck in attaining the leadership position. It has acquired patents for its CRISPR technology in Australia, China, Canada, Europe, and Korea for its in-house alternate CRISPR technology. In 2018, Merck partnered with Tongji University (China) and offered its genome-editing technology to Tongji University under the CRISPR Core Partnership Program, which has brought together around 82 organizations using CRISPR technology.

We can help with your specific research requirement for this market. Please share your specific interest to help us serve you better, Request Sample Pages:-

Unternehmensinformation / Kurzprofil:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.


PresseKontakt / Agentur:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: sales(at)


Vor- / Nachname: marketsandmarkets

Ansprechpartner: Mr. Shelly Singh
Stadt: northbrook
Telefon: 8886006441

Keywords (optional):
crispr-technology-market, crispr-technology, crispr-market, crispr, crispr-marketsandmarkets, global-crispr-market,

Dieser Artikel wurde bisher 66 mal aufgerufen.


Direkter Link zu diesem Artikel:

Diese Pressemeldung bookmarken bei...

Tausendreporter BlinkList Folkd Furl Google Linkarena Mister Wong oneview Yahoo MyWeb YiGG Webnews Technorati

Über einen Link auf Ihrer News-, Presse- oder Partner-Seite würden wir uns sehr freuen.

Hiermit versichert der Erfasser, dass der eingestellte Artikel der Wahrheit entspricht. Er ist frei von Rechten Dritter und steht zur Veröffentlichung bereit. Die Haftung für eventuelle Folgen (z.B. Abmahnungen, Schadenersatzforderungen etc.) übernimmt der Eintrager und nicht

[ Anfrage per Mail | Fehlerhaften Artikel melden | Druckbare Version | Diesen Artikel an einen Freund senden ]

Alle Artikel von marketsandmarkets RSS Feed

FDA bestätigt das Phagenyx® System, welches mittels Behandlung von neurogener Dysphagie die sichere Entfernung der Beatmungskanüle beschleunigt, als Breaktrough Device
Evolution 2.0 Prize: Erstmalige Dotierung von 10 Mio. US-Dollar für das Replizieren der zellulären Evolution
LumiThera schließt zweite Tranche einer Serie C-Finanzierung ab
Dr. Mark Bittinger wechselt als globaler Leiter des Bereichs Biologie zu Sai Life Sciences
Jennewein Biotechnologie setzt ihre Patente im Bereich humaner Milchzucker gegen Nestlé in Deutschland durch

Blogverzeichnis - Blog Verzeichnis bloggerei.deBlog Top Liste - by